Flowserve swing check valves help increase reliability in chemical applications

Published: 5-Mar-2010
Manufacturing

Redesigned Flowserve Noble Alloy swing check valve offers corrosion resistance and high reliability

Flowserve swing check valves help increase reliability in chemical applications
Flowserve Corporation, a leading provider of flow control products and services for the global infrastructure markets, today introduced the redesigned Flowserve Noble Alloy swing check valve, which offers corrosion resistance and high reliability in severe service chemical applications.

The new design introduces casting technology in lieu of forgings, which reduces the weight of the valve by 45% and offers enhanced bonnet-seal performance. The valve features a recessed hinge pin that is protected from the flow path, integral seat design and a high integrity riveted disc assembly. The valve can be installed horizontally or vertically.

'Flowserve's foundry specialises in the alloys and highly engineered casting processes that helped to create the redesigned Noble Alloy swing check valve,' said Brian Hood, product manager, Flowserve Flow Control Division. 'Even in the most challenging applications, this valve delivers improved performance for customers" most severe applications while helping reduce life-cycle costs.'

The Noble Alloy swing check valve is available with soft or metal seating. It features multiple end connections and bolted bonnet construction.

Noble Alloy also offers a wafer piston check design in cast and forged technology. Forged metal construction remains available for all Noble Alloy valve designs.
See more

You may also like

Training & Education
Flowserve opens training centre in Italy

Flowserve opens training centre in Italy

Read more
Adds to global network of Learning Resource Centres

Trending Articles

  1. Sterling Pharma Solutions doubles ADC manufacturing capacity at Deeside with new GMP suite The multi-million-pound expansion adds a 1400 sqft Grade C cleanroom, OEB5 containment handling and a 3400 sqft analytical laboratory — extending Sterling's bioconjugation capability from development through to Phase III and commercial scale
  2. FDA inspection readiness: Preparing for surveillance and pre-approval inspections Preparing pharma and biotech teams for continuous FDA inspection readiness, mock inspections and proactive regulatory risk management
  3. Hovione to install first ConsiGma CDC Flex continuous tableting line in US The CDMO is investing $35m in a next-generation continuous tableting line at its 89 Twin Rivers facility in New Jersey, creating an integrated US pathway from spray-dried amorphous solid dispersions to commercial tablet production
  4. SCHOTT Pharma makes decarbonisation measurable Validated carbon footprint tool supports informed Scope 3 reduction decisions for pharmaceutical packaging
  5. FDA Form 483 explained: responding to findings and managing regulatory risk Explore what a Form FDA 483 means, how to respond within 15 business days, assess patient risk, address observations and understand how FDA evaluates responses and inspection outcomes

You may also like

Training & Education

Flowserve opens training centre in Italy

Adds to global network of Learning Resource Centres
Manufacturing
New Flowserve digital positioner features predictive diagnostics

New Flowserve digital positioner features predictive diagnostics

Flowserve Corporation, a leading provider of flow control products and services for the global infrastructure markets, has announced the release of the Flowserve Logix 3400MD, the newest member of the Logix series digital positioner family
Manufacturing
Patented device reinvents Solid Phase Extraction

Patented device reinvents Solid Phase Extraction

Biotech Fluidics announce SPEedy - a device that provides an effortless way to perform Solid Phase Extraction (SPE) sample preparation procedures without need of an external vacuum and compatible with any adsorption chemistry or eluent composition
Manufacturing
Orano Med inaugurates Europe's first industrial-scale lead-212 radioligand therapy facility

Orano Med inaugurates Europe's first industrial-scale lead-212 radioligand therapy facility

The €29m ATLab site will target up to 10,000 doses annually and its two-hour proximity to major European airports meets the critical 24-hour production-to-administration window imposed by lead-212's 10.6-hour half-life
Manufacturing
Lonza advances aseptic spray drying for high-dose biologics

Lonza advances aseptic spray drying for high-dose biologics

This new technology platform addresses stability, concentration, and delivery challenges in biologics, including new modalities
Manufacturing
Catalent launches ten-month gene-to-drug substance programme for complex biologics

Catalent launches ten-month gene-to-drug substance programme for complex biologics

The accelerated pathway extends the CDMO's Rapid Antibody framework to bispecifics and next-generation formats — targeting master cell bank release by month seven and bulk drug substance lot release by month ten
Design & Build
Sterling Pharma Solutions doubles ADC manufacturing capacity at Deeside with new GMP suite

Sterling Pharma Solutions doubles ADC manufacturing capacity at Deeside with new GMP suite

The multi-million-pound expansion adds a 1400 sqft Grade C cleanroom, OEB5 containment handling and a 3400 sqft analytical laboratory — extending Sterling's bioconjugation capability from development through to Phase III and commercial scale
Subscribe now